Characterization & Use of Microphysiological Systems (MPS) in Pharmaceutical Safety & ADME Applications

Time: 9:10 am
day: Day One


  • Introducing an organotypic manuscript series from IQ MPS Affiliate for several key drug safety and disposition target tissues (lung, liver, kidney, skin, gastrointestinal, cardiovascular, and blood brain barrier/central nervous system)
  • Defining contexts of use, key characterization data, and platform components needed for incorporation of MPS in pharmaceutical safety screening including a list of characteristic functions, cell types, toxicities, and test agents (representing major mechanisms of toxicity) that can be used by MPS developers